Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-052421
Filing Date
2020-04-28
Accepted
2020-04-28 16:28:43
Documents
4
Period of Report
2020-06-24
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2017795d1_def14a.htm DEF 14A 372026
2 GRAPHIC page-01.jpg GRAPHIC 133449
3 GRAPHIC page-02.jpg GRAPHIC 90170
4 GRAPHIC sig.jpg GRAPHIC 3938
  Complete submission text file 0001104659-20-052421.txt   686961
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 20825481
SIC: 2834 Pharmaceutical Preparations